ConductScience.org, home

Paper24288331

Hepatitis C virus E2 envelope glycoprotein core structure.

Kong L and 11 others. Science, 2013. Cited by 335 papers, by iCite.

Cite this record

ConductScience Library. Hepatitis C virus E2 envelope glycoprotein core structure. Papers, record 24288331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24288331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatitis C virus E2 envelope glycoprotein core structure.
PubMed
Journal
Science
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
335
iCite
Relative citation ratio, by iCite
9.62
iCite
Revised in PubMed
2022-03-09
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kong LLeopold
2Giang EErick
3Nieusma TTravis
4Kadam RURameshwar U
5Cogburn KEKristin E
6Hua YYuanzi
7Dai XXiaoping
8Stanfield RLRobyn L
9Burton DRDennis R
10Ward ABAndrew B
11Wilson IAIan A
12Law MMansun

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Viral Envelope ProteinsMajor topic
Antibodies, Neutralizing
Antiviral Agents
Binding Sites
Crystallography, X-Ray
Drug Design
Epitopes
Humans
Immunoglobulin Fab Fragments
Mutagenesis, Site-Directed
Protein Folding
Protein Structure, Tertiary
Tetraspanin 28
Viral Hepatitis Vaccines

Source PubMed

Download CSV of topics

Grants16

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
RR017573NCRR NIH HHSUnited StatesP41RR017573PubMed and NIHNIH RePORTER
P41 GM103310NIGMS NIH HHSUnited StatesP41GM103310PubMed and NIHNIH RePORTER
P41 RR017573NCRR NIH HHSUnited StatesP41RR017573PubMed and NIHNIH RePORTER
U54 GM094586NIGMS NIH HHSUnited StatesU54GM094586PubMed and NIHNIH RePORTER
P41 RR001209NCRR NIH HHSUnited StatesP41RR001209PubMed and NIHNIH RePORTER
AI071084NIAID NIH HHSUnited StatesR01AI071084PubMed and NIHNIH RePORTER
AI080916NIAID NIH HHSUnited StatesR21AI080916PubMed and NIHNIH RePORTER
AI084817NIAID NIH HHSUnited StatesR01AI084817PubMed and NIHNIH RePORTER
AI079031NIAID NIH HHSUnited StatesR01AI079031PubMed and NIHNIH RePORTER
R21 AI080916NIAID NIH HHSUnited StatesR21AI080916PubMed and NIHNIH RePORTER
P41RR001209NCRR NIH HHSUnited StatesP41RR001209PubMed and NIHNIH RePORTER
R01 AI084817NIAID NIH HHSUnited StatesR01AI084817PubMed and NIHNIH RePORTER
R01 AI071084NIAID NIH HHSUnited StatesR01AI071084PubMed and NIHNIH RePORTER
R56 AI084817NIAID NIH HHSUnited StatesR01AI084817PubMed and NIHNIH RePORTER
R01 AI079031NIAID NIH HHSUnited StatesR01AI079031PubMed and NIHNIH RePORTER
R56AI084817NIHNIH RePORTER

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122623528Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22623528PubMed
223273918Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry.Cell Rep2013https://conductscience.org/library/papers/23273918PubMed
319009252Nomenclature and numbering of the hepatitis C virus.Methods Mol Biol2009https://conductscience.org/library/papers/19009252PubMed
416193056Structural basis of West Nile virus neutralization by a therapeutic antibody.Nature2005https://conductscience.org/library/papers/16193056PubMed
521124458Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography.Nature2010https://conductscience.org/library/papers/21124458PubMed
621124457Structural changes of envelope proteins during alphavirus fusion.Nature2010https://conductscience.org/library/papers/21124457PubMed
719710151Blocking hepatitis C virus infection with recombinant form of envelope protein 2 ectodomain.J Virol2009https://conductscience.org/library/papers/19710151PubMed
819207969The global burden of hepatitis C.Liver Int2009https://conductscience.org/library/papers/19207969PubMed
916912317Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.J Virol2006https://conductscience.org/library/papers/16912317PubMed
1023292515Functional and evolutionary insight from the crystal structure of rubella virus protein E1.Nature2013https://conductscience.org/library/papers/23292515PubMed
1119759151Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus.J Virol2009https://conductscience.org/library/papers/19759151PubMed
1218025038The hepatitis C sequence database in Los Alamos.Nucleic Acids Res2008https://conductscience.org/library/papers/18025038PubMed
1320174556The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule.PLoS Pathog2010https://conductscience.org/library/papers/20174556PubMed
1419251591Antibody recognition of a highly conserved influenza virus epitope.Science2009https://conductscience.org/library/papers/19251591PubMed
1510861927A model for the hepatitis C virus envelope glycoprotein E2.Proteins2000https://conductscience.org/library/papers/10861927PubMed
1623572554Identification of rodent homologs of hepatitis C virus and pegiviruses.mBio2013https://conductscience.org/library/papers/23572554PubMed
1722351712The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.Ann Intern Med2012https://conductscience.org/library/papers/22351712PubMed
1822973046Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33.J Virol2012https://conductscience.org/library/papers/22973046PubMed
199292018Characterization of truncated forms of hepatitis C virus glycoproteins.J Gen Virol1997https://conductscience.org/library/papers/9292018PubMed
2011226150CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs.EMBO J2001https://conductscience.org/library/papers/11226150PubMed

See all 35 referencesDownload CSV of references

Cited by268

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 335 citations.

PMIDTitleJournalYearIn PapersSource
42862868Structural and biochemical insights into HCV envelope proteins for germline-targeting vaccines.PLoS Pathog2026https://conductscience.org/library/papers/42862868PubMed
42642377Structure-based design of stable recombinant hepatitis C virus E1E2 heterodimers.Nat Commun2026https://conductscience.org/library/papers/42642377PubMed
42550688The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages.Cell Rep2026https://conductscience.org/library/papers/42550688PubMed
42009696Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2.NPJ Vaccines2026https://conductscience.org/library/papers/42009696PubMed
41949449Parallel Sequencing of the Two Arms on a Bispecific Antibody by Electron Capture Dissociation on a timsOmni Platform Reveals Several By-products in the Controlled Fab-arm Exchange Process.Anal Chem2026https://conductscience.org/library/papers/41949449PubMed
41673395Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.Nat Commun2026https://conductscience.org/library/papers/41673395PubMed
41481431Antibody responses to a highly conserved peptide in HCV E2 protein correlate with chronicity or spontaneous clearance of HCV infection.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41481431PubMed
41278942Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design.bioRxiv2025https://conductscience.org/library/papers/41278942PubMed
41212443HCV genotyping and rational computational designing of an immunogenic multiepitope vaccine against genotype 3a.J Comput Aided Mol Des2025https://conductscience.org/library/papers/41212443PubMed
41076628Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine design.Cell Rep2025https://conductscience.org/library/papers/41076628PubMed
40940609Targets of protective immunity and opportunities in hepatitis C virus vaccine development.Nat Rev Immunol2026https://conductscience.org/library/papers/40940609PubMed
40910688Hepatitis C virus modified SE2F442NYT-mRNA-LNP candidate vaccine promotes helper CXCR5+T cells.J Virol2025https://conductscience.org/library/papers/40910688PubMed
40750750Glycoproteins in Viruses.Methods Mol Biol2025https://conductscience.org/library/papers/40750750PubMed
40500295Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity.NPJ Vaccines2025https://conductscience.org/library/papers/40500295PubMed
40442315Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers.Commun Biol2025https://conductscience.org/library/papers/40442315PubMed
40319577Glucose-regulated protein 94 (Grp94/gp96) in viral pathogenesis: Insights into its role and therapeutic potentials.Eur J Med Chem2025https://conductscience.org/library/papers/40319577PubMed
39642219Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies.Sci Adv2024https://conductscience.org/library/papers/39642219PubMed
39232167Mapping glycoprotein structure reveals Flaviviridae evolutionary history.Nature2024https://conductscience.org/library/papers/39232167PubMed
39232163The hepatitis C virus envelope protein complex is a dimer of heterodimers.Nature2024https://conductscience.org/library/papers/39232163PubMed
39205311Update on Hepatitis C Vaccine: Results and Challenges.Viruses2024https://conductscience.org/library/papers/39205311PubMed

See all 268 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD81975PubTator's text mininghttps://conductscience.org/library/genes/975NCBI Gene
ERVK-20100616444PubTator's text mininghttps://conductscience.org/library/genes/100616444NCBI Gene
FANCB2187PubTator's text mininghttps://conductscience.org/library/genes/2187NCBI Gene
IGHV1-6928461PubTator's text mininghttps://conductscience.org/library/genes/28461NCBI Gene
IGKV2D-3028881PubTator's text mininghttps://conductscience.org/library/genes/28881NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
PDB4MWF

Source PDB

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24288331

GET https://conductscience.org/api/papers/v1/24288331/references?page=2